SEC Filings

SEC Filings

Filing date	Description	Form	View
Jan 20, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-003732.pdf 0001181431-10-003732.rtf
Jan 19, 2010	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	View HTML 0001193125-10-008211.pdf 0001193125-10-008211.rtf 0001193125-10-008211.xls
Jan 15, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-006887.pdf 0001193125-10-006887.rtf 0001193125-10-006887.xls
Jan 14, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-006088.pdf 0001193125-10-006088.rtf 0001193125-10-006088.xls
Dec 11, 2009	Amendment to a previously filed 4	4/A	View HTML 0001181431-09-056152.pdf 0001181431-09-056152.rtf
Dec 02, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-09-054420.pdf 0001181431-09-054420.rtf
Nov 19, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-238448.pdf 0001193125-09-238448.rtf 0001193125-09-238448.xls
Nov 16, 2009	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001193125-09-235633.pdf 0001193125-09-235633.rtf 0001193125-09-235633.xls
Nov 12, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-231944.pdf 0001193125-09-231944.rtf 0001193125-09-231944.xls
Nov 10, 2009	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000053417-09-000160.pdf 0000053417-09-000160.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE